Department of Gastroenterology, Surgical Division, University of Sao Paulo, São Paulo, Brazil.
Ann Surg Oncol. 2012 Apr;19(4):1324-5. doi: 10.1245/s10434-011-2072-x. Epub 2011 Oct 15.
The most favorable long-term survival rate for hilar cholangiocarcinoma is achieved by a R0 resection. A surgical concept involving a no-touch technique, with extended right hepatic resections and principle en bloc portal vein resection was described by Neuhaus et al. According to Neuhaus et al., their technique may increase the chance of R0, because the right branch of the portal vein and hepatic artery is in close contact with the tumor and is frequently infiltrated. The left artery runs on the left margin of the hilum and often is free. The 5-year survival rate for their patients is 61% but 60-day mortality rate is 8%. Given the increased morbidity, some authors do not agree with routine resection of portal vein and may perform the resection of portal vein only on demand, after intraoperative assessment and confirmation of portal vein invasion. This video shows en bloc resection of extrahepatic bile ducts, portal vein bifurcation, and right hepatic artery, together with extended right trisectionectomy (removal of segments 1, 4, 5, 6, 7, and 8).
A 75-year-old man with progressive jaundice due to right-sided hilar cholangiocarcinoma underwent percutaneous biliary drainage with metallic stents for palliation. The patient was referred for a second opinion. Serum bilirubin levels were normal, and CT scan showed a resectable tumor, but volumetry showed a small left liver remnant. Right portal vein embolization was then performed, and CT scan performed after 4 weeks showed adequate compensatory hypertrophy of the future liver remnant (segments 2 and 3). Surgical decision was to perform a right trisectionectomy with en bloc portal vein and bile duct resection using the no-touch technique.
The operation began with hilar lymphadenectomy. The common bile duct is sectioned. Right hepatic artery is ligated. Left hepatic artery is encircled. Portal vein is dissected and encircled. Right liver is mobilized and detached from retrohepatic vena cava. Right and middle hepatic veins are divided. A right trisectionectomy along with segment 1 is performed, leaving specimen attached only by the portal vein. Portal vein is severed above and below the tumor, and specimen is removed. Portal vein anastomosis is done end-to-end with 6-0 Prolene. Doppler confirms normal portal flow. The procedure ends with Roux-Y hepaticojejunostomy. The patient recovered uneventfully, without transfusion, and was discharged on the tenth postoperative day. Final pathology confirmed hilar cholangiocarcinoma and R0 resection. Portal vein showed microscopic invasion. Patient is well with no evidence of the disease 14 months after the procedure.
Right trisectionectomy with en bloc portal vein and bile duct resection is feasible and may enhance chance for R0 resection and a better late outcome, especially in cases when portal vein is microscopically involved. Although described in 1999, there are few detailed descriptions of this procedure, and to the best of our knowledge, no multimedia articles are available. This video may help oncological surgeons to perform and standardize this challenging procedure.
肝门部胆管癌获得长期生存的最有利因素是 R0 切除。Neuhaus 等人描述了一种涉及无接触技术的手术概念,包括扩大右肝切除术和原则性整块门静脉切除术。根据 Neuhaus 等人的观点,他们的技术可能会增加 R0 的机会,因为门静脉的右支和肝动脉与肿瘤密切接触且经常受到浸润。他们的患者 5 年生存率为 61%,但 60 天死亡率为 8%。鉴于发病率增加,一些作者不同意常规切除门静脉,仅在术中评估和确认门静脉侵犯后,根据需要进行门静脉切除术。本视频显示了肝外胆管、门静脉分叉和右肝动脉的整块切除,以及扩大的右三叶切除术(切除第 1、4、5、6、7 和 8 段)。
一名 75 岁男性因右侧肝门部胆管癌导致进行性黄疸而行经皮胆道金属支架引流姑息治疗。该患者因再次就诊。血清胆红素水平正常,CT 扫描显示可切除肿瘤,但体积测量显示左肝小叶较小。然后对右门静脉进行栓塞,4 周后的 CT 扫描显示未来肝残的代偿性肥大(第 2 和 3 段)。手术决策是采用无接触技术进行右三叶切除术,整块切除门静脉和胆管。
手术开始进行肝门淋巴结清扫。胆总管被切开。右肝动脉被结扎。左肝动脉被环绕。门静脉被解剖和环绕。右肝被游离并从肝后下腔静脉上分离。右中肝静脉被分开。沿第 1 段进行右三叶切除术,仅通过门静脉将标本附着。在肿瘤上方和下方切断门静脉,并切除标本。门静脉端端吻合用 6-0 Prolene 进行。多普勒确认门静脉血流正常。手术结束时行 Roux-Y 肝肠吻合术。患者术后恢复顺利,无输血,术后第 10 天出院。最终病理证实为肝门部胆管癌和 R0 切除。门静脉显示显微镜下侵犯。术后 14 个月,患者无疾病证据,状况良好。
右三叶切除术联合整块门静脉和胆管切除术是可行的,可能增强 R0 切除和更好的晚期结果的机会,特别是在门静脉显微镜下受累的情况下。尽管该手术于 1999 年描述,但很少有详细的描述,据我们所知,也没有多媒体文章。本视频可能有助于肿瘤外科医生进行并规范这一具有挑战性的手术。